Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.0.1460081
European Journal of Endocrinology, Vol 146, Issue 1, 81-88
Copyright © 2002 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winkelmann, J
Right arrow Articles by Stalla, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winkelmann, J
Right arrow Articles by Stalla, G.
Case Reports

Retention of dopamine 2 receptor mRNA and absence of the protein in craniospinal and extracranial metastasis of a malignant prolactinoma: a case report

J Winkelmann, U Pagotto, M Theodoropoulou, K Tatsch, W Saeger, A Muller, T Arzberger, L Schaaf, EM Schumann, C Trenkwalder, and GK Stalla

Department of Neurology, Max-Planck-Institute of Psychiatry, Kraepelinstrasse 10, 80804 Munich, Germany. janew@mpipsykl.mpg.de

OBJECTIVES: The case presented here describes the clinical evolution of a malignant prolactinoma with occurrence of intra- and extra-cranial metastases. In this case, the presence of dopamine 2 receptor (D2R) was studied at the mRNA and protein level, in order to understand the pathological background of the resistance to treatment with different dopamine agonists. DESIGN: Together with an extensive description of the clinical history of this case, a combination of in vitro and in vivo techniques was performed to provide the basis of the dopamine resistance developed in the course of the disease. METHOD: A comparison of the D2R was performed in specimens obtained at presentation of the disease compared with autoptic specimens derived from local invasion and metastasis using in situ hybridization and immunohistochemical techniques. RESULTS: Intact D2R mRNA was found in the primitive tumor and metastatic tissues, whereas protein for the same receptor was present only in the tissues derived from neurosurgical operations and not in the metastases obtained post-mortem. CONCLUSION: This is the first report of the absence of D2R protein despite the retention of the transcript in an advanced stage of a malignant prolactinoma. The findings of this single case suggest the hypothesis that postranscriptional mechanisms may contribute to the development of dopamine resistance in prolactinomas.


This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
S. Bondioni, A. R. Angioni, S. Corbetta, M. Locatelli, S. Ferrero, E. Ferrante, G. Mantovani, L. Olgiati, P. Beck-Peccoz, A. Spada, et al.
Effect of 9-cis Retinoic Acid on Dopamine D2 Receptor Expression in Pituitary Adenoma Cells
Experimental Biology and Medicine, April 1, 2008; 233(4): 439 - 446.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. Kars, F. Roelfsema, J. A Romijn, and A. M Pereira
Malignant prolactinoma: case report and review of the literature.
Eur. J. Endocrinol., October 1, 2006; 155(4): 523 - 534.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. P. Gillam, M. E. Molitch, G. Lombardi, and A. Colao
Advances in the Treatment of Prolactinomas
Endocr. Rev., August 1, 2006; 27(5): 485 - 534.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. A. Kaltsas, P. Nomikos, G. Kontogeorgos, M. Buchfelder, and A. B. Grossman
Diagnosis and Management of Pituitary Carcinomas
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3089 - 3099.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
A. Lania, G. Mantovani, and A. Spada
Genetics of Pituitary Tumors: Focus on G-Protein Mutations
Experimental Biology and Medicine, October 1, 2003; 228(9): 1004 - 1017.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 European Society of Endocrinology.